UBS Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $52

Benzinga · 1d ago
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.